(ATHA)


Exchange


Currency in (Disclaimer)
Volume:
Day's Range:

ATHA Insider Transactions

Transaction Date
(SEC Report )
Reporting Name Relationship Shrs. Owned Type Acq./Disp. Shrs. Transacted Price() Amount()
2023-01-27 Litton Mark James director, officer: Chief Executive Officer 425,000 A-Award A 425,000 4.11 1,746,750.00
2023-01-19 MILESON GLENNA officer: Chief Financial Officer 150,000 A-Award A 150,000 3.37 505,500.00
2023-01-19 MOEBIUS HANS officer: Chief Medical Officer 200,000 A-Award A 200,000 3.37 674,000.00
2023-01-19 Worthington Mark officer: General Counsel 150,000 A-Award A 150,000 3.37 505,500.00
2023-01-19 Lenington Rachel officer: Chief Operating Officer 200,000 A-Award A 200,000 3.37 674,000.00
2023-01-19 CHURCH KEVIN officer: Executive VP, Research 150,000 A-Award A 150,000 3.37 505,500.00
2022-12-28 MILESON GLENNA officer: Chief Financial Officer 159,930 P-Purchase A 50,000 2.85 142,250.00
2022-12-02 Romano Kelly A director 38,315 P-Purchase A 30,000 3.29 98,700.00
2022-11-18 Litton Mark James director, officer: Chief Executive Officer 129,217 A-Award A 662 2.74 1,813.88
2022-11-18 CHURCH KEVIN officer: Executive VP, Research 62,052 A-Award A 657 2.74 1,800.18
2022-11-18 MILESON GLENNA officer: Chief Financial Officer 109,930 A-Award A 763 2.74 2,090.62
2022-11-15 MOEBIUS HANS officer: Chief Medical Officer 65,836 P-Purchase A 5,000 3.29 16,442.00
2022-10-28 CHURCH KEVIN officer: Executive VP, Research 6,410 M-Exempt D 3,700 1.35 4,995.00
2022-10-28 CHURCH KEVIN officer: Executive VP, Research 61,395 M-Exempt A 3,700 1.35 4,995.00
2022-10-13 MOEBIUS HANS officer: Chief Medical Officer 7,882 M-Exempt D 7,881 1.35 10,639.35
2022-10-13 MOEBIUS HANS officer: Chief Medical Officer 60,836 M-Exempt A 7,881 1.35 10,639.35
2022-06-30 PERCEPTIVE ADVISORS LLC director, 10 percent owner 4,797,278 P-Purchase A 1,101,362 2.99 3,293,072.38
2022-06-29 PERCEPTIVE ADVISORS LLC director, 10 percent owner 3,695,916 P-Purchase A 270,000 2.99 807,300.00
2022-06-28 MOEBIUS HANS officer: Chief Medical Officer 52,955 P-Purchase A 10,000 2.88 28,800.00
2022-06-23 Worthington Mark officer: General Counsel 19,097 S-Sale D 2,614 2.69 7,031.66
2022-06-23 Litton Mark James director, officer: Chief Executive Officer 128,555 S-Sale D 7,960 2.69 21,412.40
2022-06-23 MILESON GLENNA officer: Chief Financial Officer 109,167 S-Sale D 2,614 2.69 7,031.66
2022-06-23 Lenington Rachel officer: Chief Operating Officer 5,807 S-Sale D 4,193 2.69 11,279.17
2022-06-23 CHURCH KEVIN officer: Executive VP, Research 57,695 S-Sale D 2,614 2.69 7,031.66
2022-06-22 Worthington Mark officer: General Counsel 21,711 A-Award A 10,000 0.00 0.00
2022-06-22 MOEBIUS HANS officer: Chief Medical Officer 42,955 A-Award A 10,000 0.00 0.00
2022-06-22 Litton Mark James director, officer: Chief Executive Officer 136,515 A-Award A 20,000 0.00 0.00
2022-06-22 MILESON GLENNA officer: Chief Financial Officer 111,781 A-Award A 10,000 0.00 0.00
2022-06-22 Lenington Rachel officer: Chief Operating Officer 10,000 A-Award A 10,000 0.00 0.00
2022-06-22 CHURCH KEVIN officer: Executive VP, Research 60,309 A-Award A 10,000 0.00 0.00
2022-06-08 CHURCH KEVIN officer: Executive VP, Research 10,110 M-Exempt D 2,500 1.35 3,375.00
2022-06-08 CHURCH KEVIN officer: Executive VP, Research 50,309 M-Exempt A 2,500 1.35 3,375.00
2022-05-20 Kosacz Barbara director 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-20 Panzara Michael A. director 2,311 A-Award A 2,311 8.93 20,637.23
2022-05-20 FLUKE JOHN M JR director 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-20 Romano Kelly A director 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-20 PICKERING GRANT director 3,467 A-Award A 3,467 8.93 30,960.31
2022-05-20 JOHNSON JAMES A director 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-20 EDELMAN JOSEPH director 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-20 PERCEPTIVE ADVISORS LLC director, 10 percent owner 13,871 A-Award A 13,871 8.93 123,868.03
2022-05-18 Worthington Mark officer: General Counsel 11,711 A-Award A 3,396 7.06 23,975.76
2022-05-18 MOEBIUS HANS officer: Chief Medical Officer 32,955 A-Award A 1,699 7.06 11,994.94
2022-05-18 Litton Mark James director, officer: Chief Executive Officer 116,515 A-Award A 757 7.06 5,344.42
2022-05-18 MILESON GLENNA officer: Chief Financial Officer 101,781 A-Award A 1,721 7.06 12,150.26
2022-05-18 CHURCH KEVIN officer: Executive VP, Research 47,809 A-Award A 243 7.06 1,715.58
2022-04-11 MILESON GLENNA officer: Chief Financial Officer 167,000 M-Exempt D 3,000 10.64 31,920.00
2022-04-11 MILESON GLENNA officer: Chief Financial Officer 100,060 M-Exempt A 3,000 10.64 31,920.00
2022-03-31 Romano Kelly A director 8,315 P-Purchase A 8,000 13.11 104,880.00
2022-03-18 Panzara Michael A. director 27,742 A-Award A 27,742 10.62 294,620.04
2022-02-18 CHURCH KEVIN officer: Executive VP, Research 0 M-Exempt D 3,152 1.19 3,750.88
2022-02-18 CHURCH KEVIN officer: Executive VP, Research 47,566 M-Exempt A 3,152 1.19 3,750.88
2022-01-27 Litton Mark James director, officer: Chief Executive Officer 400,000 A-Award A 400,000 9.91 3,964,000.00
2022-01-27 PICKERING GRANT director 27,742 A-Award A 27,742 9.91 274,923.22
2022-01-18 Lenington Rachel officer: Chief Operating Officer 180,000 A-Award A 180,000 10.64 1,915,200.00
2022-01-18 MILESON GLENNA officer: Chief Financial Officer 170,000 A-Award A 170,000 10.64 1,808,800.00
2022-01-18 CHURCH KEVIN officer: Executive VP, Research 100,000 A-Award A 100,000 10.64 1,064,000.00
2022-01-18 MOEBIUS HANS officer: Chief Medical Officer 180,000 A-Award A 180,000 10.64 1,915,200.00
2022-01-18 Worthington Mark officer: General Counsel 150,000 A-Award A 150,000 10.64 1,596,000.00
2022-01-04 MILESON GLENNA officer: Chief Financial Officer 0 M-Exempt D 6,305 1.35 8,511.75
2022-01-04 MILESON GLENNA officer: Chief Financial Officer 97,060 M-Exempt A 6,305 1.35 8,511.75
2021-11-18 Litton Mark James director, officer: Chief Executive Officer 115,758 A-Award A 885 12.51 11,071.35
2021-11-18 CHURCH KEVIN officer: Executive VP, Research 44,414 A-Award A 96 12.51 1,200.96
2021-11-18 MOEBIUS HANS officer: Chief Medical Officer 31,256 A-Award A 829 12.51 10,370.79
2021-11-18 MILESON GLENNA officer: Chief Financial Officer 90,755 A-Award A 931 12.51 11,646.81
2021-11-03 Lenington Rachel officer: Chief Operating Officer 150,000 A-Award A 150,000 15.34 2,301,000.00
2021-11-03 Worthington Mark officer: General Counsel 150,000 A-Award A 150,000 15.34 2,301,000.00
2021-08-17 Litton Mark James officer: Chief Operating Officer 114,873 M-Exempt A 50,440 1.35 68,094.00
2021-08-17 Litton Mark James officer: Chief Operating Officer 100,880 M-Exempt D 50,440 1.35 68,094.00
2021-07-21 MOEBIUS HANS officer: Chief Medical Officer 0 M-Exempt D 12,610 1.35 17,023.50
2021-07-21 MOEBIUS HANS officer: Chief Medical Officer 30,427 M-Exempt A 15,762 1.35 21,278.70
2021-07-21 MOEBIUS HANS officer: Chief Medical Officer 14,665 M-Exempt A 12,610 1.35 17,023.50
2021-07-21 MOEBIUS HANS officer: Chief Medical Officer 15,763 M-Exempt D 15,762 1.35 21,278.70
2021-06-15 FLUKE JOHN M JR director 144,884 J-Other A 1,000 0.00 0.00
2021-06-15 FLUKE JOHN M JR director 3,731 J-Other D 3,000 0.00 0.00
2021-06-10 MILESON GLENNA officer: Chief Financial Officer 89,824 M-Exempt A 6,305 1.35 8,511.75
2021-06-10 MILESON GLENNA officer: Chief Financial Officer 6,305 M-Exempt D 6,305 1.35 8,511.75
2021-06-08 CHURCH KEVIN officer: Vice President of Discovery 0 M-Exempt D 3,152 1.04 3,278.08
2021-06-08 CHURCH KEVIN officer: Vice President of Discovery 44,133 M-Exempt A 3,152 1.04 3,278.08
2021-06-08 CHURCH KEVIN officer: Vice President of Discovery 44,318 M-Exempt A 3,152 1.04 3,278.08
2021-05-28 JOHNSON JAMES A director 13,871 A-Award A 13,871 19.94 276,587.74
2021-05-28 FLUKE JOHN M JR director 13,871 A-Award A 13,871 19.94 276,587.74
2021-05-28 Yamada Tadataka director 13,871 A-Award A 13,871 19.94 276,587.74
2021-05-28 PERCEPTIVE ADVISORS LLC director, 10 percent owner 13,871 A-Award A 13,871 19.94 276,587.74
2021-05-28 EDELMAN JOSEPH director, 10 percent owner 13,871 A-Award A 13,871 19.94 276,587.74
2021-05-18 MOEBIUS HANS officer: Chief Medical Officer 2,055 A-Award A 2,055 14.45 29,694.75
2021-05-18 Litton Mark James officer: Chief Operating Officer 64,433 A-Award A 867 14.45 12,528.15
2021-05-18 CHURCH KEVIN officer: Vice President of Discovery 41,166 A-Award A 185 14.45 2,673.25
2021-05-18 MILESON GLENNA officer: Chief Financial Officer 83,519 A-Award A 1,554 14.45 22,455.30
2021-03-04 Kosacz Barbara director 27,742 A-Award A 27,742 19.29 535,143.18
2021-02-18 Litton Mark James officer: Chief Operating Officer 85,000 A-Award A 85,000 21.15 1,797,750.00
2021-02-18 CHURCH KEVIN officer: Vice President of Discovery 20,000 A-Award A 20,000 21.15 423,000.00
2021-02-18 KAWAS LEEN director, officer: President & CEO 231,000 A-Award A 231,000 21.15 4,885,650.00
2021-02-18 MILESON GLENNA officer: Chief Financial Officer 73,500 A-Award A 73,500 21.15 1,554,525.00
2021-02-18 MOEBIUS HANS officer: Chief Medical Officer 72,000 A-Award A 72,000 21.15 1,522,800.00
2021-02-03 FLUKE JOHN M JR director 140,101 M-Exempt A 25,220 1.19 30,011.80
2021-02-03 FLUKE JOHN M JR director 143,884 M-Exempt A 3,783 1.35 5,107.05
2021-02-03 FLUKE JOHN M JR director 0 M-Exempt D 25,220 1.19 30,011.80
2021-01-25 PERCEPTIVE ADVISORS LLC director, 10 percent owner 3,425,916 P-Purchase A 311,111 22.50 6,999,997.50
2020-12-22 Romano Kelly A director 315 L-Small A 315 31.74 9,999.08
2020-12-11 Romano Kelly A director 27,742 A-Award A 27,742 29.41 815,892.22

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.